Biocatalytic strategies for the asymmetric synthesis of profens - Recent trends and developments

Robert Kourist, Pablo Domínguez De María, Kenji Miyamoto

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The profen family belongs to the most important non-steroidal anti-inflammatory drugs (NSAIDs). A considerable number of biocatalytic processes for the synthesis of optically pure (S)-profens have been proposed. Despite of the excellent enantioselectivity and the large advantages that enzyme catalysis offers in terms of sustainability, biocatalytic processes have failed so far to meet the technical and economic challenges of commercialization. This critical review outlines recent trends and developments of novel applications that appear very promising in terms of enantioselectivity, efficiency, sustainability and yield. Special emphasis is placed on the contribution of protein engineering in overcoming the limitations of these enzymes for technical applications, and thus providing promising biocatalysts for the preparation of pharmaceutical products. The natural catalytic diversity, assisted by modern methods of protein engineering, provides novel concepts and leads for the environmentally friendly synthesis of pharmacologically important drugs. Considerable progress can be expected in the coming decades. Furthermore, aspects regarding ecological footprints and the impact of each biocatalytic route are critically addressed, considering aspects like the type of solvent, waste produced, availability of substrate, etc. When possible, suggestions for combining efficiency with more sustainable synthetic approaches are also given.

Original languageEnglish
Pages (from-to)2607-2618
Number of pages12
JournalGreen Chemistry
Volume13
Issue number10
DOIs
Publication statusPublished - 2011 Oct

Fingerprint

Enantioselectivity
Sustainable development
drug
Enzymes
Proteins
Biocatalysts
sustainability
Pharmaceutical Preparations
Drug products
enzyme
Catalysis
engineering
ecological footprint
protein
Availability
commercialization
catalysis
Economics
Anti-Inflammatory Agents
Substrates

ASJC Scopus subject areas

  • Environmental Chemistry
  • Pollution

Cite this

Biocatalytic strategies for the asymmetric synthesis of profens - Recent trends and developments. / Kourist, Robert; Domínguez De María, Pablo; Miyamoto, Kenji.

In: Green Chemistry, Vol. 13, No. 10, 10.2011, p. 2607-2618.

Research output: Contribution to journalArticle

Kourist, Robert ; Domínguez De María, Pablo ; Miyamoto, Kenji. / Biocatalytic strategies for the asymmetric synthesis of profens - Recent trends and developments. In: Green Chemistry. 2011 ; Vol. 13, No. 10. pp. 2607-2618.
@article{fcc4be798eb144b68c942b595fe38b30,
title = "Biocatalytic strategies for the asymmetric synthesis of profens - Recent trends and developments",
abstract = "The profen family belongs to the most important non-steroidal anti-inflammatory drugs (NSAIDs). A considerable number of biocatalytic processes for the synthesis of optically pure (S)-profens have been proposed. Despite of the excellent enantioselectivity and the large advantages that enzyme catalysis offers in terms of sustainability, biocatalytic processes have failed so far to meet the technical and economic challenges of commercialization. This critical review outlines recent trends and developments of novel applications that appear very promising in terms of enantioselectivity, efficiency, sustainability and yield. Special emphasis is placed on the contribution of protein engineering in overcoming the limitations of these enzymes for technical applications, and thus providing promising biocatalysts for the preparation of pharmaceutical products. The natural catalytic diversity, assisted by modern methods of protein engineering, provides novel concepts and leads for the environmentally friendly synthesis of pharmacologically important drugs. Considerable progress can be expected in the coming decades. Furthermore, aspects regarding ecological footprints and the impact of each biocatalytic route are critically addressed, considering aspects like the type of solvent, waste produced, availability of substrate, etc. When possible, suggestions for combining efficiency with more sustainable synthetic approaches are also given.",
author = "Robert Kourist and {Dom{\'i}nguez De Mar{\'i}a}, Pablo and Kenji Miyamoto",
year = "2011",
month = "10",
doi = "10.1039/c1gc15162b",
language = "English",
volume = "13",
pages = "2607--2618",
journal = "Green Chemistry",
issn = "1463-9262",
publisher = "Royal Society of Chemistry",
number = "10",

}

TY - JOUR

T1 - Biocatalytic strategies for the asymmetric synthesis of profens - Recent trends and developments

AU - Kourist, Robert

AU - Domínguez De María, Pablo

AU - Miyamoto, Kenji

PY - 2011/10

Y1 - 2011/10

N2 - The profen family belongs to the most important non-steroidal anti-inflammatory drugs (NSAIDs). A considerable number of biocatalytic processes for the synthesis of optically pure (S)-profens have been proposed. Despite of the excellent enantioselectivity and the large advantages that enzyme catalysis offers in terms of sustainability, biocatalytic processes have failed so far to meet the technical and economic challenges of commercialization. This critical review outlines recent trends and developments of novel applications that appear very promising in terms of enantioselectivity, efficiency, sustainability and yield. Special emphasis is placed on the contribution of protein engineering in overcoming the limitations of these enzymes for technical applications, and thus providing promising biocatalysts for the preparation of pharmaceutical products. The natural catalytic diversity, assisted by modern methods of protein engineering, provides novel concepts and leads for the environmentally friendly synthesis of pharmacologically important drugs. Considerable progress can be expected in the coming decades. Furthermore, aspects regarding ecological footprints and the impact of each biocatalytic route are critically addressed, considering aspects like the type of solvent, waste produced, availability of substrate, etc. When possible, suggestions for combining efficiency with more sustainable synthetic approaches are also given.

AB - The profen family belongs to the most important non-steroidal anti-inflammatory drugs (NSAIDs). A considerable number of biocatalytic processes for the synthesis of optically pure (S)-profens have been proposed. Despite of the excellent enantioselectivity and the large advantages that enzyme catalysis offers in terms of sustainability, biocatalytic processes have failed so far to meet the technical and economic challenges of commercialization. This critical review outlines recent trends and developments of novel applications that appear very promising in terms of enantioselectivity, efficiency, sustainability and yield. Special emphasis is placed on the contribution of protein engineering in overcoming the limitations of these enzymes for technical applications, and thus providing promising biocatalysts for the preparation of pharmaceutical products. The natural catalytic diversity, assisted by modern methods of protein engineering, provides novel concepts and leads for the environmentally friendly synthesis of pharmacologically important drugs. Considerable progress can be expected in the coming decades. Furthermore, aspects regarding ecological footprints and the impact of each biocatalytic route are critically addressed, considering aspects like the type of solvent, waste produced, availability of substrate, etc. When possible, suggestions for combining efficiency with more sustainable synthetic approaches are also given.

UR - http://www.scopus.com/inward/record.url?scp=80053548516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053548516&partnerID=8YFLogxK

U2 - 10.1039/c1gc15162b

DO - 10.1039/c1gc15162b

M3 - Article

VL - 13

SP - 2607

EP - 2618

JO - Green Chemistry

JF - Green Chemistry

SN - 1463-9262

IS - 10

ER -